[{"address1": "1200 Brickell Avenue", "address2": "Suite 1950 #1183", "city": "Miami", "state": "FL", "zip": "32183", "country": "United States", "phone": "786 432 9792", "website": "https://mirapharmaceuticals.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Erez  Aminov", "age": 46, "title": "CEO & Chairman", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 626193, "exercisedValue": 0, "unexercisedValue": 113700}, {"maxAge": 1, "name": "Mr. Alan  Weichselbaum CPA, M.B.A.", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Itzchak  Angel Ph.D.", "title": "Chief Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.61, "open": 1.63, "dayLow": 1.61, "dayHigh": 1.69, "regularMarketPreviousClose": 1.61, "regularMarketOpen": 1.63, "regularMarketDayLow": 1.61, "regularMarketDayHigh": 1.69, "payoutRatio": 0.0, "beta": 1.813, "forwardPE": -3.9756098, "volume": 926502, "regularMarketVolume": 926502, "averageVolume": 3001761, "averageVolume10days": 271900, "averageDailyVolume10Day": 271900, "bid": 1.11, "ask": 1.9, "bidSize": 2, "askSize": 2, "marketCap": 68258024, "fiftyTwoWeekLow": 0.73, "fiftyTwoWeekHigh": 2.45, "allTimeHigh": 7.98, "allTimeLow": 0.51, "fiftyDayAverage": 1.4743, "twoHundredDayAverage": 1.331215, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 60722116, "profitMargins": 0.0, "floatShares": 34944338, "sharesOutstanding": 41876087, "sharesShort": 273552, "sharesShortPriorMonth": 516658, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0064999997, "heldPercentInsiders": 0.16653, "heldPercentInstitutions": 0.032479998, "shortRatio": 0.84, "shortPercentOfFloat": 0.0074, "impliedSharesOutstanding": 41876087, "bookValue": 0.191, "priceToBook": 8.534032, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -28415680, "trailingEps": -1.6, "forwardEps": -0.41, "52WeekChange": 0.5333333, "SandP52WeekChange": 0.1340276, "quoteType": "EQUITY", "currentPrice": 1.63, "targetHighPrice": 17.75, "targetLowPrice": 17.75, "targetMeanPrice": 17.75, "targetMedianPrice": 17.75, "recommendationMean": 0.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 7535905, "totalCashPerShare": 0.18, "totalDebt": 0, "quickRatio": 89.792, "currentRatio": 90.53, "returnOnAssets": -0.74644995, "returnOnEquity": -1.2332599, "freeCashflow": -2723576, "operatingCashflow": -5331662, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MIRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1691069400000, "postMarketChangePercent": -0.56441575, "postMarketPrice": 1.6208, "postMarketChange": -0.009199977, "regularMarketChange": 0.02, "shortName": "MIRA Pharmaceuticals, Inc.", "longName": "MIRA Pharmaceuticals, Inc.", "postMarketTime": 1766192054, "regularMarketTime": 1766178002, "exchange": "NCM", "messageBoardId": "finmb_1793899557", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.24223, "regularMarketPrice": 1.63, "regularMarketDayRange": "1.61 - 1.69", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 3001761, "fiftyTwoWeekLowChange": 0.9, "fiftyTwoWeekLowChangePercent": 1.2328767, "fiftyTwoWeekRange": "0.73 - 2.45", "fiftyTwoWeekHighChange": -0.82000005, "fiftyTwoWeekHighChangePercent": -0.33469388, "fiftyTwoWeekChangePercent": 53.33333, "marketState": "CLOSED", "corporateActions": [], "epsTrailingTwelveMonths": -1.6, "epsForward": -0.41, "fiftyDayAverageChange": 0.15569997, "fiftyDayAverageChangePercent": 0.10560942, "twoHundredDayAverageChange": 0.29878497, "twoHundredDayAverageChangePercent": 0.22444531, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-08-03", "averageAnalystRating": "0.0 - Strong Buy", "cryptoTradeable": false, "displayName": "MIRA Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]